Impact of COVID-19 on Vaccines Market | Global Opportunity Analysis and Industry Forecast 2019-2027

Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccines are biological agents that elicit an immune response against a specific antigen derived from the disease-causing pathogen. The development of vaccine has led to the eradication of various infectious diseases such as smallpox and polio, which are now completely eliminated from many countries, including countries located within North & Latin America and Europe. Further, with the advancements in vaccine production techniques and an increase in adoption, it is speculated that the other pandemic diseases will soon be eliminated like other diseases.

Vaccination is based on the principle of altering immunity by inducing the multiplication of specialized cells, mainly lymphocytes, which either kill virus-infected cells by direct contact or through proteins they secrete. The induced immune response against disease-causing organisms through vaccine configures the body’s immune cells in such a way so that they become capable of quickly recognizing and reacting to the same antigen in a more powerful manner when encountered again. Thus, due to the vaccine’s high potential in the prevention of diseases, the development of new vaccines is growing exponentially with incessant launch of new vaccines and many candidates in pipelines. According to the World Health Organization (WHO), as of September 2018, across all cases of infectious diseases, around 463 products are in pipeline. The top products in pipelines include vaccines 240 in number when compared to 138 as of May 2017 followed by diagnostics (93) and medicines (81). Similarly, according to Pharmaceutical Research and Manufacturers of America (PhRMA), in 2018, around 1,100 medicines and vaccines were in the development stage in the U.S. for cancer treatment as compared to 900 medicines and vaccines in 2012.

The global vaccines market is expected to growat a CAGR of 5.2% from 2019 to 2027 to reach $62.16 billion by 2027.The growth in this market is majorly driven by factors such as strong pipeline for vaccines, increasing government focus on immunization programs, and technological progress in vaccine administration. In addition, increasing epidemic potentials and growing focus on therapeutic vaccines, and growth prospects in emerging markets are expected to offer significant growth opportunities for the players operating in the vaccines market. However, the high cost associated with vaccine development and longer timelines for vaccine manufacturing hinders the growth of this market.

The global vaccines market studied in this report is segmented on the basis of indication (Pneumococcal disease, Influenza, Human Papilloma Virus (HPV), DTP, meningococcal disease, rotavirus, poliomyelitis, MMR, hepatitis, and others), route of administration (intramuscular, subcutaneous, oral, others), antigen type (subunit & conjugate, inactivated, live-attenuated, toxoid, combination), valence (multivalent, monovalent), and geography.

On the basis of indication, the pneumococcal disease segment commanded the largest share of the global vaccines market in 2019. The major share of this segment is primarily attributed to the rising incidence of pneumococcal diseases like pneumonia, meningitis, febrile bacteraemia, otitis media, and sinusitis; the development of quality vaccines such as PPSV23; and initiatives by government organizations and private sectors to prevent and control the outbreak of pneumococcal diseases. Owing to these reasons, the demand for pneumococcal vaccines is consistently increasing globally, thereby driving the growth of this market.

To gain more insights into the market with a detailed table of content and figures, with free sample report, click here: https://www.meticulousresearch.com/request-sample-report/cp_id=5076

Scope of the Report:

Global Vaccines Market, by Indication

• Pneumococcal Disease

• Influenza

• DTP

• Human Papilloma Virus (HPV)

• Meningococcal Disease

• Poliomyelitis (Polio)

• MMR

• Rotavirus

• Hepatitis

• Other Indications (Note: Other indications include varicella, herpes zoster vaccines, chlorella, and rabies vaccines.)

Global Vaccines Market, by Route of Administration

• Intramuscular (IM)

• Subcutaneous (SC)

• Oral

• Other Routes (Note: Other routes include intradermal (ID), transcutaneous (TC), and nasal route)

Global Vaccines Market, by Type/Antigen

• Subunit & Conjugate Vaccines

• Inactivated vaccines

• Live Attenuated Vaccines

• Toxoid vaccines

• Combination Vaccines

Global Vaccines Market, by Valence

• Multivalent Vaccines

• Monovalent vaccines

Global Vaccines Market, by Geography

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • Rest of Europe (RoE)

• Asia-Pacific (APAC)

  • Japan

  • China

  • India

  • Rest of APAC (RoAPAC)

• Latin America

• Middle East & Africa ….Continue

Additional Insights-

In addition to global opportunity analysis and market forecasts, the Vaccines Market study provides detailed insights on regulatory analysis, product pipeline analysis, pricing analysis, and unmet need analysis. The study also showcases competitive benchmarking for top market players, by product and geography. The competitive landscape of this study also provides market share analysis, by market players and vaccines brand.

Some of the key players operating in the global vaccines market are Sanofi (France), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Daiichi Sankyo Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), and AstraZeneca (U.K.) among others.

TOP 10 VACCINES MANUFACTURERS 2019

Key questions answered in the report-

What is Vaccines Market?

What are the market size forecasts and CAGR from the period 2019-2027?

Which are the largest and fastest growing vaccine types of the market?

What are the major drivers of the market?

What are the major restraints of the global vaccines market?

What are the major opportunities in the global market?

What are the major challenges in the global market?

Who are the major key players operating in the global vaccines market?

What are high growth countries/regions in the market?

Download Free Sample Report for future analysis @ https://www.meticulousresearch.com/download-sample-report/cp_id=5076

Browse More Report of This Category at:

Microfluidic Immunoassay Market by Product Type (Lab-on-chip, POC Analyzers, Reagents and Assay), Technology, Application (Cardiac, Troponin, BNP) - Global Forecast to 2025

Real World Evidence Solutions Market by Component (RWD, EMR, Claim, Patient Registry, Pharmacy, Service), Application (Oncology, CVD, Neuro, Infection, Regulatory), End User (Pharma, Biotech, Medical Devices, Payers, Healthcare) - Global Forecast to 2024

Pharmaceutical Processing and Packaging Equipment Market by Mode of Drug Delivery (Oral, Parenteral, Topical), Secondary Packaging (Cartoning, Labeling), and End-Of-Line (Case Packaging, Palletizing, and Depalletizing) - Global Forecast to 2025